timkiely, It appears that some of your research could be flawed as a result of quoting extracts from NRMA material instead of MHRA. Regards........................................
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025